Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC
Elise A. Olsen(Durham Technical Community College), Julia Scarisbrick(University Hospital of Zurich), José Antônio Sanches(Universidade de São Paulo), Alejandro A. Gru(University of Virginia), Madeleine Duvic(Cancer Clinic), H. Miles Prince(Peter MacCallum Cancer Centre), Robert Knobler(Medical University of Vienna), Pablo L. Ortiz‐Romero(Hospital Universitario 12 De Octubre), Werner Kempf(University Hospital of Zurich), Wei Ai(University of California, San Francisco), Gary S. Wood(University of Wisconsin–Madison), Emmilia Hodak(Rabin Medical Center), Lawrence Schwartz(Columbia University Irving Medical Center), Michael Girardi(Yale University), Pietro Quaglino(Department of Medical Sciences), John A. Zic(Vanderbilt University), Evangelia Papadavid(National and Kapodistrian University of Athens), Makoto Sugaya(International University of Health and Welfare), M. Bagot(Inserm), Rein Willemze(Leiden University Medical Center), Emmanuella Guenova(Johannes Kepler University of Linz), Mark R. Pittelkow(Mayo Clinic in Arizona), Lauren Pinter‐Brown(University of California, Irvine), Maarten H. Vermeer(Leiden University Medical Center), Richard T. Hoppe(Stanford Medicine), Joan Guitart(Northwestern Memorial Hospital), Mary Jo Lechowicz(Emory University), Francine M. Foss(Yale Cancer Center), Sean Whittaker(Guy's Hospital), Sarah McCue Horwitz(New York University), Ellen Kim(Peter MacCallum Cancer Centre), Jasmine M. Zain(City Of Hope National Medical Center), Rudolf Stadler(University Hospitals of the Ruhr-University of Bochum), Youn H. Kim(Stanford University), Larisa J. Geskin(Columbia University Irving Medical Center)
Cited by 170
Related Papers
Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
|Journal of Clinical Oncology|2011|657
Pivotal Phase III Trial of Two Dose Levels of Denileukin Diftitox for the Treatment of Cutaneous T-Cell Lymphoma
|Journal of Clinical Oncology|2001|610
Mental Health Service Use in the Community and Schools: Results from the Four-Community MECA Study
|Journal of the American Academy of Child & Adolescent Psychiatry|1996|609